Skip to main navigation
logo
Investors
  • News Archive
  • Past Events and Presentations
  • Stock History

News Archive

News Archive

May 04, 2020
Mylan Releases "A Legacy of Impact: 2019 Global Social Responsibility Report"
Apr 28, 2020
Mylan and Biocon Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada
Apr 24, 2020
Mylan to Release First Quarter 2020 Financial Results on May 11, 2020
Apr 22, 2020
Mylan Statement Regarding European Commission’s Conditional Approval of the Combination of Mylan and Pfizer’s Upjohn Division
Apr 15, 2020
Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V.
Apr 08, 2020
Mylan Updates Its Efforts Regarding COVID-19
Mar 27, 2020
Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept
Mar 26, 2020
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 25, 2020
Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusivity in the U.S. for Lopinavir/Ritonavir to Help Ensure Wider Availability to Meet Potential COVID-19 Patient Needs
Mar 25, 2020
Mylan Statement Regarding India Manufacturing Facilities

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »
Share

Utility Nav

  • Privacy Statement
  • Terms and Conditions
©2023 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.
mylan